Sentinel lymph node scintigraphy in skin melanoma: personal experience
- Autores: Trofimchuk L.Y.1, Afanasieva N.G.1
-
Afiliações:
- Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine
- Edição: Volume 30, Nº 6/7 (2023)
- Páginas: 90-93
- Seção: Original articles
- URL: https://journal-vniispk.ru/2073-4034/article/view/275524
- DOI: https://doi.org/10.18565/pharmateca.2023.6-7.90-93
- ID: 275524
Citar
Acesso aberto
Acesso está concedido
Somente assinantes
Resumo
Background. The technique for studying sentinel lymph nodes (SLN) makes it possible to objectively visualize the direction of lymph drainage from the area of the tumor location, to perform targeted biopsy of the lymph node and morphological exa- mination.
Objective. Evaluation of the effectiveness of lymphoscintigraphy in detecting SLN in patients with localized skin melanoma, comparison of the planar lymphoscintigraphy and SPECT/CT, comparison of the effectiveness of radiopharmaceuticals (RP) Technefit-99mTc and Nanotop-99mTc, presentation of our own results.
Methods. 182 SLN scintigraphic studies with Technefit-99mTc or Nanotop-99mTc were performed in patients with localized skin melanoma. The radiopharmaceutical was administered at four points intradermally along the periphery of the formation or scar. Planar scintigraphy (96 examinations) or SPECT/CT (86 examinations) was performed. After lymphoscintigraphy, an intraoperative search for SLN followed by urgent histological verification was performed.
Results. According to our data, the SLN detection rate was 95.1%, according to planar lymphoscintigraphy – 94.8%, SPECT/CT – 95.3%. With the introduction of «Technefit-99mTc», the SLN detection rate was 93.8%, with the introduction of «Nanotop-99mTc» – 97.1%. In most cases, lymph nodes detected by scintigraphy revealed intraoperatively (93.4%). Metastases in the SLN during urgent histological verification were detected in 20 patients.
Discussion. Negative results of lymphoscintigraphy and intraoperative data may be related to the particle size of Technefit-99mTc. The SLN detection only by the lymphoscintigraphy is probably associated with the close localization of the lymphatic collector to the tumor, which made it difficult to search for SLN intraoperatively.
Conclusion. The use of radiopharmaceuticals «Technefit-99mTc» and «Nanotop-99mTc» showed high efficiency in detecting SLN. The difference between planar scintigraphy and SPECT/CT is insignificant, however, the use of SPECT/CT helps to accurately target the SLN, this is especially true when the mass is localized near the lymphatic collector.
Palavras-chave
Texto integral
##article.viewOnOriginalSite##Sobre autores
Lyudmila Trofimchuk
Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine
Autor responsável pela correspondência
Email: trofimchuklyu@inbox.ru
ORCID ID: 0000-0002-3240-2915
Radiologist, Department of Radionuclide Diagnostics
Rússia, ChelyabinskN. Afanasieva
Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine
Email: trofimchuklyu@inbox.ru
ORCID ID: 0000-0003-3874-5449
Rússia, Chelyabinsk
Bibliografia
- Clark W.H., Jr., Elder D.E., Guerry Dt. et al. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol. 1984; 15(12):1147–65. doi: 10.1016/s0046-8177(84)80310-x.
- Barr R.D., Ries L.A., Lewis D.R. et al.; US National Cancer Institute Science of Adolescent and Young Adult Oncology Epidemiology Working Group. Incidence and incidence trends of the most frequent cancers in adolescent and young adult Americans, including «nonmalignant/noninvasive» tumors. Cancer. 2016;122(7):1000-8. doi: 10.1002/cncr.29867.
- Group U.S.C.S.W. United States Cancer Statistics: 1999–2013 Incidence and Mortality Webbased Report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute ‒2016 (access date: August 1, 2016).
- Анисимов В.В., Семилетова Ю.В., Барчук А.С. и др. Актуальные вопросы хирургического лечения больных первичной меланомой кожи. Cибирский онкологический журнал. 2010; 2(38):55–8. [Anisimov V.V., Semiletova Yu.V., Barchuk A.S. et al. Problems in surgical treatment of patients with primary skin melanoma. Sibirskiy Onkologicheskiy Zhurnal=Siberian J Oncol. 2010;2(38): 55–8 (In Russ.)].
- Демидов Л.В., Барышников К.А., Мартынова Е.В. и др. Широкое иссечение – несовременный стандарт хирургического лечения первичной меланомы кожи. Cаркомы костей, мягких тканей и опухоли кожи. 2013;1:54–9. [Demidov L.V., Baryshnikov K.A., Martynova E.V. et al. Wide excision shoud not be considered as standart of care for primary cutaneous melanoma. Sarkomy Kostey, Myagkikh Tkaney i Opukholi Kozhi=Bone and Soft Tissue Sarcomas and Tumors of the Skin. 2013;1:54–9 (In Russ.)].
- Braun-Falco O., Landthaler M., Hölzel D., et al. Therapy and prognosis of malignant melanoma of the skin. Dtsch Med Wochenschr. 1986;111(46):1750–56. doi: 10.1055/s-2008-1068704.
- Leong S.P. Paradigm of metastasis for melanoma and breast cancer based on the sentinel lymph node experience. Ann Surg Oncol. 2004;11:192–97. doi: 10.1007/BF02523627.
- Morton D.L., Thompson J.F., Cochran A.J. et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370(7):599–609. doi: 10.1056/NEJMoa1310460.
- Morera-Sendra N., Tejera-Vaquerizo A., Traves V., et al. Value of sentinel lymph node biopsy and adjuvant interferon treatment in thick (>4 mm) cutaneous melanoma: an observational study. Eur J Dermatol. 2016;26(1):34–48. doi: 10.1684/ejd.2015.2693.
Arquivos suplementares
